Summary
Boston Scientific Corporation (BSX) has filed an 8-K report on February 1, 2023, primarily to announce its fourth quarter and full-year financial results for the period ending December 31, 2022. The report itself does not contain the detailed financial results but rather furnishes a press release (Exhibit 99.1) where these results are disclosed. Investors should refer to this press release for comprehensive information regarding the company's performance in the fourth quarter and the entirety of 2022. The filing is procedural, confirming the public release of this important financial information.
Key Highlights
- 1Boston Scientific Corporation released its Q4 and full-year 2022 financial results via a press release filed on February 1, 2023.
- 2The 8-K filing serves as notification and includes the press release as an exhibit.
- 3Investors need to consult the furnished press release (Exhibit 99.1) for specific financial performance details.
- 4The information provided is not deemed 'filed' for purposes of Section 18 of the Exchange Act, meaning it's not subject to liabilities under that specific section.
- 5This filing is a standard procedure for announcing material financial outcomes.